|
Q2 FY2027
As of Jul 31, 2026
|
Q1 FY2027
As of Apr 30, 2026
|
Q4 FY2026
As of Jan 31, 2026
|
Q3 FY2026
As of Oct 31, 2025
|
Q2 FY2026
As of Jul 31, 2025
|
Q1 FY2026
As of Apr 30, 2025
|
Q4 FY2025
As of Jan 31, 2025
|
Q3 FY2025
As of Oct 31, 2024
|
Q2 FY2025
As of Jul 31, 2024
|
Q1 FY2025
As of Apr 30, 2024
|
|
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Cash and cash equivalents | ||||||||||
| Short-term investments | ||||||||||
| Accounts receivable, net of allowances of $941 and $299 | ||||||||||
| Deferred commissions | ||||||||||
| Prepaid expenses and other current assets | ||||||||||
| Total current assets | ||||||||||
| Noncurrent assets | ||||||||||
| Property and equipment, net | ||||||||||
| Deferred commissions, noncurrent | ||||||||||
| Goodwill | ||||||||||
| Other assets, noncurrent | ||||||||||
| Total assets | ||||||||||
| Liabilities and stockholders’ deficit | ||||||||||
| Current liabilities | ||||||||||
| Accounts payable | ||||||||||
| Accrued expenses and other current liabilities | ||||||||||
| Deferred revenue | ||||||||||
| Total current liabilities | ||||||||||
| Deferred revenue, noncurrent | ||||||||||
| Other liabilities, noncurrent | ||||||||||
| Convertible senior notes, net | ||||||||||
| Debt, noncurrent | ||||||||||
| Total liabilities | ||||||||||
| Redeemable convertible preferred stock, $0.000025 par value – zero and $74,182,559 shares authorized as of January 31, 2025 and 2024, respectively; zero and $74,182,559 shares issued and outstanding as of January 31, 2025 and 2024, respectively; liquidation preference of zero and $715,100 as of January 31, 2025 and 2024, respectively | ||||||||||
| Stockholders’ deficit | ||||||||||
| Preferred stock, $0.000025 par value – $20,000,000 shares authorized as of July 31, 2026 and January 31, 2026; zero shares issued and outstanding as of July 31, 2026 and January 31, 2026 | ||||||||||
| Common stock | ||||||||||
| Class A | ||||||||||
| Class B | ||||||||||
| Additional paid-in capital | ||||||||||
| Accumulated other comprehensive (loss) income | ||||||||||
| Accumulated deficit | ||||||||||
| Total stockholders’ deficit | ||||||||||
| Total liabilities and stockholders’ deficit | ||||||||||
| Preferred stock, outstanding (in shares) | ||||||||||
| Preferred stock, authorized (in shares) | ||||||||||
| Preferred stock, issued (in shares) | ||||||||||
| Preferred stock, par value (in dollars per share) | ||||||||||
| Common stock, authorized (in shares) | ||||||||||
| Class A | ||||||||||
| Class B |
Loading...